Breast Cancer
ER- breast cancer cell ERa re-expression recreate hormone-responsive phenotype
Published in Women's Health Weekly, July 8th, 2004
"Estrogen receptor (ER)-negative breast carcinomas are often difficult to treat with antiestrogens. This work was performed to determine if the re-expression of the human ERalpha could restore the hormone response of these cells. We have transfected the human wild-type ERalpha to an ER-negative breast cancer cell line (MDA-MB-231) using a tetracycline-regulated gene expression system," investigators in Mexico reported.
"We obtained a new cell line, MDA-A4-5/2. Cell count and flow cytometry ''S'' phase cell fraction showed that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Assisted Reproduction
ART can't compensate for waiting too long to start a family - Breast Cancer
Study offers new target to stop cancer growth - Endocrinology
Animal study reveals negative adrenocortical effects of long-term estrogen - Hormone Replacement Therapy
New study finds estrogen use doesn't reduce dementia risk in older women - Polycystic Ovary Syndrome
Study finds rosiglitazone a "promising, well-tolerated" treatment for PCOS - Adrenal Incidentaloma
Female AI patients with hypercortisolism are at risk for low spinal BMD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
